RUBIUS THERAPEUTICS INC (RUBY)

US78116T1034 - Common Stock

0.083  -0.04 (-33.55%)

After market: 0.0899 +0.01 (+8.31%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
127.25M194.62M166.45M169.60M91.66M
Research and Development
96.41M141.59M116.11M112.42M51.77M
Selling, General, and Administrative Expenses
30.84M53.03M50.34M57.18M39.89M
Operating Income
-127.25M-194.62M-166.45M-169.60M-91.66M
Interest Income/Expense
-4.14M-6.34M-2.43M5.40M4.66M
Other Income/Expense
1.82M4.41M1.14M740.00K-2.19M
Non Recurring Items
-50.10MN/AN/AN/AN/A
Income Before Taxes
-179.67M-196.55M-167.73M-163.46M-89.20M
Net Income
-179.67M-196.55M-167.73M-163.46M-89.20M
EBITDA
-121.00M-186.89M-160.76M-166.60M-90.40M
 
Per Share Data
EPS Diluted Total Ops
-1.99-2.23-2.08-2.08-1.12
Non GAAP EPS
N/A-2.23-2.08-2.07N/A
 
Statistics

All data in USD

Charts